Endothelial Expression of Scavenger Receptor Class B, Type i Protects against Development of Atherosclerosis in Mice

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Vaisman, Boris L ^a   Vishnyakova, Tatyana G ^b   Freeman, Lita A ^a   Amar, Marcelo J ^a   Demosky, Stephen J ^a   Liu, Chengyu ^c   Stonik, John A ^a   Sampson, Maureen L ^a   Pryor, Milton ^a   Bocharov, Alexander V ^b   Eggerman, Thomas L ^b   Patterson, Amy P ^b   Remaley, Alan T ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; SCAVENGER RECEPTOR BI; SCARB1 PROTEIN, MOUSE; SCAVENGER RECEPTOR B;

ANIMAL CELL; AORTA INJURY; APICAL MEMBRANE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BASOLATERAL MEMBRANE; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; LIVER; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; AORTA; BIOLOGICAL MODEL; BLOOD; C57BL MOUSE; CHEMISTRY; CYTOLOGY; FEMALE; GENETICS; METABOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; ENDOTHELIUM, VASCULAR; FEMALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; SCAVENGER RECEPTORS, CLASS B;

EID: 84945271991     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/607120     Document Type: Article

References (46)

1. D. J. Rader and A. Daugherty, "Translating molecular discoveries into new therapies for atherosclerosis, " Nature, vol. 451, no. 7181, pp. 904-913, 2008.
2. P. Libby, P. M. Ridker, and G. K. Hansson, "Progress and challenges in translating the biology of atherosclerosis, " Nature, vol. 473, no. 7347, pp. 317-325, 2011.
3. Y. V. Bobryshev, "Monocyte recruitment and foam cell formation in atherosclerosis, " Micron, vol. 37, no. 3, pp. 208-222, 2006.
4. D. J. Rader, "Molecular regulation of HDL metabolism and function: implications for novel therapies, " The Journal of Clinical Investigation, vol. 116, no. 12, pp. 3090-3100, 2006.
5. C. Besler, T. F. Luscher, and U. Landmesser, "Molecular mechanisms of vascular effects ofHigh-density lipoprotein: alterations in cardiovascular disease, " EMBO Molecular Medicine, vol. 4, no. 4, pp. 251-268, 2012.
6. J. A. Glomset, "The plasma lecithins: cholesterol acyltransferase reaction, " Journal of Lipid Research, vol. 9, no. 2, pp. 155-167, 1968.
7. D. J. Rader, E. T. Alexander, G. L. Weibel, J. Billheimer, andG.H. Rothblat, "The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis, " Journal of Lipid Research, vol. 50, pp. S189-S194, 2009.
8. L. Rohrer, P. M. Ohnsorg, M. Lehner, F. Landolt, F. Rinninger, and A. Von Eckardstein, "High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1, " Circulation Research, vol. 104, no. 10, pp. 1142-1150, 2009.
9. A. von Eckardstein and L. Rohrer, "Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins, " CurrentOpinion in Lipidology, vol. 20, no. 3, pp. 197-205, 2009.
10. B. L. Vaisman, S. J. Demosky, J. A. Stonik et al., "Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis, " Journal of Lipid Research, vol. 53, no. 1, pp. 158-167, 2012.
11. U. Panzenboeck, Z. Balazs, A. Sovic et al., "ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells, " Journal of Biological Chemistry, vol. 277, no. 45, pp. 42781-42789, 2002.
12. D. Goti, A. Hrzenjak, S. Levak-Frank et al., "Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-Associated vitamin E, " Journal of Neurochemistry, vol. 76, no. 2, pp. 498-508, 2001.
13. C. MineoandP.W. Shaul, "Functions of scavenger receptor class B, type i in atherosclerosis, " Current Opinion in Lipidology, vol. 23, no. 5, pp. 487-493, 2012.
14. A. Rigotti, B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger, "A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 23, pp. 12610-12615, 1997.
15. T. Arai, N. Wang, M. Bezouevski, C. Welch, and A. R. Tall, "Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene, " The Journal of Biological Chemistry, vol. 274, no. 4, pp. 2366-2371, 1999.
16. N. Wang, T. Arai, Y. Ji, F. Rinninger, and A. R. Tall, "Liverspecific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice, " The Journal of Biological Chemistry, vol. 273, no. 49, pp. 32920-32926, 1998.
17. T. Huby, C. Doucet, C. Dachet et al., "Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues, " Journal of Clinical Investigation, vol. 116, no. 10, pp. 2767-2776, 2006.
18. S. D. Covey, M. Krieger, W. Wang, M. Penman, and B. L. Trigatti, "Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 9, pp. 1589-1594, 2003.
19. W. Zhang, P. G. Yancey, Y. R. Su et al., "Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice, " Circulation, vol. 108, no. 18, pp. 2258-2263, 2003.
20. M. van Eck, I. S. T. Bos, R. B. Hildebrand, B. T. van Rij, and T. J. C. van Berkel, "Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development, " The American Journal of Pathology, vol. 165, no. 3, pp. 785-794, 2004.
21. Y. Pei, X. Chen, D. Aboutouk et al., "SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction, " PLoS ONE, vol. 8, no. 8, Article ID e72492, 2013.
22. L. Calabresi, M. Gomaraschi, and G. Franceschini, "Endothelial protection by high-density lipoproteins: from bench to bedside, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 10, pp. 1724-1731, 2003.
23. S. Saddar, V. Carriere, W.-R. Lee et al., "Scavenger receptor class B type I is a plasma membrane cholesterol sensor, " Circulation Research, vol. 112, no. 1, pp. 140-151, 2013.
24. R. M. McAllister, D. M. Morris, C. M. Weimer, and M. H. Laughlin, "Effects of high-density lipoprotein on endotheliumdependent vasorelaxation, " Applied Physiology, Nutrition and Metabolism, vol. 35, no. 3, pp. 319-327, 2010.
25. S. Acton, A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Kriegert, "Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, " Science, vol. 271, no. 5248, pp. 518-520, 1996.
26. T. M. Schlaeger, S. Bartunkova, J. A. Lawitts et al., "Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3058-3063, 1997.
27. P. I. Teng, M. R. Dichiara, L. G. Kömuves, K. Abe, T. Quertermous, and J. N. Topper, "Inducible and selective transgene expression inmurine vascular endothelium, " Physiological Genomics, vol. 11, no. 2, pp. 99-107, 2002.
28. C. Liu, W. Xie, C. Gui, and Y. Du, "Pronuclear microinjection and oviduct transfer procedures for transgenic mouse production, " Methods inMolecular Biology, vol. 1027, pp. 217-232, 2013.
29. X.-P. Yang, M. J. Amar, B. Vaisman et al., "Scavenger receptor-BI is a receptor for lipoprotein(a), " Journal of Lipid Research, vol. 54, no. 9, pp. 2450-2457, 2013.
30. T. D. Schmittgen and K. J. Livak, "Analyzing real-Time PCR data by the comparative T method, " Nature Protocols, vol. 3, no. 6, pp. 1101-1108, 2008.
31. H. E. Miettinen, H. Rayburn, and M. Krieger, "Abnormal lipoproteinmetabolism and reversible female infertility inHDL receptor (SR-BI)-deficient mice, " Journal of Clinical Investigation, vol. 108, no. 11, pp. 1717-1722, 2001.
32. E. V. Jokinen, K. T. Landschulz, K. L. Wyne, Y. K. Ho, P. K. Frykman, and H.H. Hobbs, "Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletalmuscle, " The Journal of Biological Chemistry, vol. 269, no. 42, pp. 26411-26418, 1994.
33. A. M. Berard, B. Föger, A. Remaley et al., "High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase, " Nature Medicine, vol. 3, no. 7, pp. 744-749, 1997.
34. E. A. Jaffe, "Cell biology of endothelial cells, " Human Pathology, vol. 18, no. 3, pp. 234-239, 1987.
35. W. C. Aird, "Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms, " Circulation Research, vol. 100, no. 2, pp. 158-173, 2007.
36. A. Yesilaltay, M. G. Morales, L. Amigo et al., "Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoproteinmetabolism and female fertility, " Endocrinology, vol. 147, no. 4, pp. 1577-1588, 2006.
37. J. Fan, J. Wang, A. Bensadoun et al., "Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins, " Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 18, pp. 8724-8728, 1994.
38. S. Ghosh, "Early steps in reverse cholesterol transport: cholesteryl ester hydrolase and other hydrolases, " Current Opinion in Endocrinology, Diabetes and Obesity, vol. 19, no. 2, pp. 136-141, 2012.
39. Z. Balazs, U. Panzenboeck, A. Hammer et al., "Uptake and transport of high-density lipoprotein (HDL) and HDL-Associated alpha-Tocopherol by an in vitro blood-brain barriermodel, " Journal of Neurochemistry, vol. 89, no. 4, pp. 939-950, 2004.
40. K. M. Argraves and W. S. Argraves, "HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects, " Journal of Lipid Research, vol. 48, no. 11, pp. 2325-2333, 2007.
41. X. Liu, S. L. Xiong, and G.-H. Yi, "ABCA1, ABCG1, and SRBI: transit ofHDL-Associated sphingosine-1-phosphate, " Clinica Chimica Acta, vol. 413, no. 3-4, pp. 384-390, 2012.
42. D. Reichl, "Extravascular circulation of lipoproteins: their role in reverse transport of cholesterol, " Atherosclerosis, vol. 105, no. 2, pp. 117-129, 1994.
43. G. J. Randolph and N. E. Miller, "Lymphatic transport of highdensity lipoproteins and chylomicrons, " The Journal of Clinical Investigation, vol. 124, no. 3, pp. 929-935, 2014.
44. O. Eliska, M. Eliskova, and A. J. Miller, "The absence of lymphatics in normal and atherosclerotic coronary arteries in man: a morphologic study, " Lymphology, vol. 39, no. 2, pp. 76-83, 2006.
45. H.H. Hassan, M. Denis, L. Krimbou, M. Marcil, and J. Genest, "Cellular cholesterol homeostasis in vascular endothelial cells, " Canadian Journal of Cardiology, vol. 22, supplement, pp. 35B-40B, 2006.
46. H. Y. Lim, C. H. Thiam, K. P. Yeo et al., "Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-Mediated transport of HDL, " Cell Metabolism, vol. 17, no. 5, pp. 671-684, 2013.